series-c-plus
Stage
1
Investors
About
Provigate develops low- and non-invasive home self-monitoring devices and apps for weekly glycoalbumin (GA) blood glucose testing to support behavior change and management of diabetes and prediabetes.
Explore Provigate, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.